View Financial HealthAllied Supreme 배당 및 자사주 매입배당 기준 점검 3/6Allied Supreme 수익으로 충분히 충당되는 현재 수익률 2.8% 보유한 배당금 지급 회사입니다.핵심 정보2.8%배당 수익률-0.003%자사주 매입 수익률총 주주 수익률2.8%미래 배당 수익률5.1%배당 성장률12.9%다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향59%최근 배당 및 자사주 매입 업데이트Upcoming Dividend • Mar 25Upcoming dividend of NT$6.00 per shareEligible shareholders must have bought the stock before 01 April 2026. Payment date: 30 April 2026. Payout ratio is on the higher end at 88%, however this is supported by cash flows. Trailing yield: 5.3%. Within top quartile of Taiwanese dividend payers (5.3%). Higher than average of industry peers (2.1%).Declared Dividend • Mar 11Dividend reduced to NT$6.00Dividend of NT$6.00 is 50% lower than last year. Ex-date: 1st April 2026 Payment date: 30th April 2026 Dividend yield will be 2.3%, which is lower than the industry average of 4.0%. Sustainability & Growth Dividend is covered by both earnings (88% earnings payout ratio) and cash flows (66% cash payout ratio). The dividend has increased by an average of 23% per year over the past 5 years and payments have been stable during that time. EPS is expected to grow by 26% over the next year, which should provide support to the dividend and adequate earnings cover.분석 기사 • Mar 13Allied Supreme (TWSE:4770) Has Announced A Dividend Of NT$12.00Allied Supreme Corp. ( TWSE:4770 ) has announced that it will pay a dividend of NT$12.00 per share on the 30th of...Declared Dividend • Mar 13Dividend of NT$12.00 announcedDividend of NT$12.00 is the same as last year. Ex-date: 27th March 2025 Payment date: 30th April 2025 Dividend yield will be 3.5%, which is lower than the industry average of 4.0%. Sustainability & Growth Dividend is covered by both earnings (56% earnings payout ratio) and cash flows (75% cash payout ratio). The dividend has increased by an average of 29% per year over the past 4 years and payments have been stable during that time. EPS is expected to grow by 19% over the next 2 years, which should provide support to the dividend and adequate earnings cover.공고 • Mar 12Allied Supreme Corp. Announces Cash Dividend Distribution for the Year 2024, Payable on April 30, 2025Allied Supreme Corp. announced cash dividend distribution for the year 2024. Type and monetary amount of common stock dividend distribution: Cash dividends: TWD 959,712,000 (TWD 12 distributed per share). Ex-rights (ex-dividend) trading date: March 27, 2025; Ex-rights (ex-dividend) record date: April 4, 2025. Payment date of common stock cash dividend distribution: April 30, 2025.Upcoming Dividend • Mar 21Upcoming dividend of NT$12.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 30 April 2024. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 2.8%. Lower than top quartile of Taiwanese dividend payers (4.7%). Lower than average of industry peers (4.1%).모든 업데이트 보기Recent updatesValuation Update With 7 Day Price Move • May 26Investor sentiment improves as stock rises 17%After last week's 17% share price gain to NT$266, the stock trades at a trailing P/E ratio of 26.2x. Average forward P/E is 20x in the Chemicals industry in Taiwan. Negligible returns to shareholders over past three years. Simply Wall St's valuation model estimates the intrinsic value at NT$303 per share.Reported Earnings • May 13First quarter 2026 earnings: EPS and revenues miss analyst expectationsFirst quarter 2026 results: EPS: NT$2.00 (down from NT$2.60 in 1Q 2025). Revenue: NT$1.06b (up 9.6% from 1Q 2025). Net income: NT$201.6m (down 3.0% from 1Q 2025). Profit margin: 19% (down from 22% in 1Q 2025). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 29%. Earnings per share (EPS) also missed analyst estimates by 52%. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.New Risk • Mar 31New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.8% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.3% average weekly change). Profit margins are more than 30% lower than last year (17% net profit margin).Upcoming Dividend • Mar 25Upcoming dividend of NT$6.00 per shareEligible shareholders must have bought the stock before 01 April 2026. Payment date: 30 April 2026. Payout ratio is on the higher end at 88%, however this is supported by cash flows. Trailing yield: 5.3%. Within top quartile of Taiwanese dividend payers (5.3%). Higher than average of industry peers (2.1%).New Risk • Mar 17New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 17% Last year net profit margin: 27% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Profit margins are more than 30% lower than last year (17% net profit margin).Reported Earnings • Mar 17Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: EPS: NT$10.20 (down from NT$21.68 in FY 2024). Revenue: NT$4.73b (down 27% from FY 2024). Net income: NT$815.9m (down 53% from FY 2024). Profit margin: 17% (down from 27% in FY 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 6.7%. Earnings per share (EPS) also missed analyst estimates by 20%. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.Declared Dividend • Mar 11Dividend reduced to NT$6.00Dividend of NT$6.00 is 50% lower than last year. Ex-date: 1st April 2026 Payment date: 30th April 2026 Dividend yield will be 2.3%, which is lower than the industry average of 4.0%. Sustainability & Growth Dividend is covered by both earnings (88% earnings payout ratio) and cash flows (66% cash payout ratio). The dividend has increased by an average of 23% per year over the past 5 years and payments have been stable during that time. EPS is expected to grow by 26% over the next year, which should provide support to the dividend and adequate earnings cover.Valuation Update With 7 Day Price Move • Mar 11Investor sentiment improves as stock rises 19%After last week's 19% share price gain to NT$262, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 19x in the Chemicals industry in Taiwan. Total loss to shareholders of 9.0% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at NT$248 per share.New Risk • Mar 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.공고 • Mar 10+ 1 more updateAllied Supreme Corp., Annual General Meeting, Jun 02, 2026Allied Supreme Corp., Annual General Meeting, Jun 02, 2026. Location: no,20, hsien kung nan 2nd rd., siansi township, changhua county TaiwanMajor Estimate Revision • Jan 15Consensus revenue estimates fall by 14%The consensus outlook for revenues in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from NT$5.50b to NT$4.73b. EPS estimate fell from NT$14.78 to NT$10.91 per share. Net income forecast to grow 17% next year vs 35% growth forecast for Chemicals industry in Taiwan. Consensus price target of NT$366 unchanged from last update. Share price fell 6.1% to NT$223 over the past week.Reported Earnings • Nov 17Third quarter 2025 earnings: EPS misses analyst expectationsThird quarter 2025 results: EPS: NT$3.05 (down from NT$5.28 in 3Q 2024). Revenue: NT$1.40b (down 21% from 3Q 2024). Net income: NT$244.0m (down 42% from 3Q 2024). Profit margin: 18% (down from 24% in 3Q 2024). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 23%. Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 6.3% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has fallen by 12% per year whereas the company’s share price has fallen by 9% per year.Buy Or Sell Opportunity • Sep 08Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 32% to NT$320. The fair value is estimated to be NT$264, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 5.1%. Revenue is forecast to grow by 5.4% in a year. Earnings are forecast to grow by 7.5% in the next year.Price Target Changed • Aug 17Price target increased by 15% to NT$367Up from NT$320, the current price target is an average from 4 analysts. New target price is 34% above last closing price of NT$275. Stock is down 29% over the past year. The company is forecast to post earnings per share of NT$14.78 for next year compared to NT$21.68 last year.Reported Earnings • Aug 13Second quarter 2025 earnings: EPS and revenues miss analyst expectationsSecond quarter 2025 results: EPS: NT$2.75 (down from NT$5.01 in 2Q 2024). Revenue: NT$1.31b (down 17% from 2Q 2024). Net income: NT$220.2m (down 45% from 2Q 2024). Profit margin: 17% (down from 25% in 2Q 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 13%. Earnings per share (EPS) also missed analyst estimates by 38%. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 3.6% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Aug 08Investor sentiment improves as stock rises 19%After last week's 19% share price gain to NT$307, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 20x in the Chemicals industry in Taiwan. Total returns to shareholders of 34% over the past three years.Valuation Update With 7 Day Price Move • Jun 20Investor sentiment improves as stock rises 17%After last week's 17% share price gain to NT$275, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 20x in the Chemicals industry in Taiwan. Total returns to shareholders of 16% over the past three years.공고 • May 30Allied Supreme Corp. Approves Board ElectionsAllied Supreme Corp. at its 2025 Annual General Shareholders meeting held on May 29, 2025, approved the election of Director: Hou, Chia-Sheng and Independent Director: Lu, Chien-Jung, Independent Director: Wang, Kui-Ching, Independent Director: Chien, Yu-Kuo and Independent Director: Chen, Yun-Chang.Reported Earnings • May 13First quarter 2025 earnings: EPS and revenues miss analyst expectationsFirst quarter 2025 results: EPS: NT$2.60 (down from NT$6.14 in 1Q 2024). Revenue: NT$965.9m (down 35% from 1Q 2024). Net income: NT$207.8m (down 58% from 1Q 2024). Profit margin: 22% (down from 33% in 1Q 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.0%. Earnings per share (EPS) also missed analyst estimates by 5.9%. Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 4.2% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.공고 • May 01Allied Supreme Corp. to Report Q1, 2025 Results on May 08, 2025Allied Supreme Corp. announced that they will report Q1, 2025 results on May 08, 2025Valuation Update With 7 Day Price Move • Apr 16Investor sentiment improves as stock rises 17%After last week's 17% share price gain to NT$234, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 17x in the Chemicals industry in Taiwan. Negligible returns to shareholders over past three years.Valuation Update With 7 Day Price Move • Mar 31Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to NT$272, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 17x in the Chemicals industry in Taiwan. Total returns to shareholders of 16% over the past three years.Major Estimate Revision • Mar 20Consensus revenue estimates fall by 14%The consensus outlook for revenues in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from NT$7.23b to NT$6.20b. EPS estimate fell from NT$24.35 to NT$18.42 per share. Net income forecast to shrink 15% next year vs 18% growth forecast for Chemicals industry in Taiwan . Consensus price target down from NT$434 to NT$384. Share price was steady at NT$343 over the past week.Price Target Changed • Mar 19Price target decreased by 14% to NT$384Down from NT$444, the current price target is an average from 2 analysts. New target price is 11% above last closing price of NT$345. Stock is down 14% over the past year. The company is forecast to post earnings per share of NT$18.42 for next year compared to NT$21.68 last year.Reported Earnings • Mar 15Full year 2024 earnings: EPS exceeds analyst expectationsFull year 2024 results: EPS: NT$21.68 (up from NT$21.22 in FY 2023). Revenue: NT$6.46b (up 13% from FY 2023). Net income: NT$1.73b (up 2.9% from FY 2023). Profit margin: 27% (down from 30% in FY 2023). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.7%. Revenue is forecast to grow 7.1% p.a. on average during the next 2 years, compared to a 4.9% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 11% per year.분석 기사 • Mar 13Allied Supreme (TWSE:4770) Has Announced A Dividend Of NT$12.00Allied Supreme Corp. ( TWSE:4770 ) has announced that it will pay a dividend of NT$12.00 per share on the 30th of...공고 • Mar 13Allied Supreme Corp., Annual General Meeting, May 29, 2025Allied Supreme Corp., Annual General Meeting, May 29, 2025, at 10:00 Taipei Standard Time. Location: no,300, ch`ing fu rd., siansi township, changhua county TaiwanDeclared Dividend • Mar 13Dividend of NT$12.00 announcedDividend of NT$12.00 is the same as last year. Ex-date: 27th March 2025 Payment date: 30th April 2025 Dividend yield will be 3.5%, which is lower than the industry average of 4.0%. Sustainability & Growth Dividend is covered by both earnings (56% earnings payout ratio) and cash flows (75% cash payout ratio). The dividend has increased by an average of 29% per year over the past 4 years and payments have been stable during that time. EPS is expected to grow by 19% over the next 2 years, which should provide support to the dividend and adequate earnings cover.공고 • Mar 12Allied Supreme Corp. Announces Cash Dividend Distribution for the Year 2024, Payable on April 30, 2025Allied Supreme Corp. announced cash dividend distribution for the year 2024. Type and monetary amount of common stock dividend distribution: Cash dividends: TWD 959,712,000 (TWD 12 distributed per share). Ex-rights (ex-dividend) trading date: March 27, 2025; Ex-rights (ex-dividend) record date: April 4, 2025. Payment date of common stock cash dividend distribution: April 30, 2025.Valuation Update With 7 Day Price Move • Mar 06Investor sentiment improves as stock rises 16%After last week's 16% share price gain to NT$372, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 20x in the Chemicals industry in Taiwan. Total returns to shareholders of 68% over the past three years.공고 • Feb 28Allied Supreme Corp. to Report Q4, 2024 Results on Mar 07, 2025Allied Supreme Corp. announced that they will report Q4, 2024 results on Mar 07, 2025New Risk • Feb 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Valuation Update With 7 Day Price Move • Feb 14Investor sentiment improves as stock rises 16%After last week's 16% share price gain to NT$330, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 17x in the Chemicals industry in Taiwan. Total returns to shareholders of 40% over the past three years.분석 기사 • Feb 14There's No Escaping Allied Supreme Corp.'s (TWSE:4770) Muted EarningsAllied Supreme Corp.'s ( TWSE:4770 ) price-to-earnings (or "P/E") ratio of 14.9x might make it look like a buy right...분석 기사 • Dec 16Why You Should Care About Allied Supreme's (TWSE:4770) Strong Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...Reported Earnings • Nov 15Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behindThird quarter 2024 results: EPS: NT$5.28 (up from NT$4.82 in 3Q 2023). Revenue: NT$1.77b (up 44% from 3Q 2023). Net income: NT$422.1m (up 10% from 3Q 2023). Profit margin: 24% (down from 31% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.3%. Earnings per share (EPS) missed analyst estimates by 5.2%. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 4.8% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 9% per year.공고 • Nov 01Allied Supreme Corp. to Report Q3, 2024 Results on Nov 08, 2024Allied Supreme Corp. announced that they will report Q3, 2024 results on Nov 08, 2024분석 기사 • Sep 04Investors Shouldn't Overlook The Favourable Returns On Capital At Allied Supreme (TWSE:4770)What trends should we look for it we want to identify stocks that can multiply in value over the long term? In a...Reported Earnings • Aug 12Second quarter 2024 earnings: EPS and revenues miss analyst expectationsSecond quarter 2024 results: EPS: NT$5.01 (up from NT$4.75 in 2Q 2023). Revenue: NT$1.59b (up 8.4% from 2Q 2023). Net income: NT$400.4m (up 6.6% from 2Q 2023). Profit margin: 25% (in line with 2Q 2023). Revenue missed analyst estimates by 1.6%. Earnings per share (EPS) also missed analyst estimates by 10%. Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 4.7% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 19% per year and the company’s share price has also increased by 19% per year.분석 기사 • Aug 08A Look At The Intrinsic Value Of Allied Supreme Corp. (TWSE:4770)Key Insights Allied Supreme's estimated fair value is NT$463 based on 2 Stage Free Cash Flow to Equity Allied Supreme's...Buy Or Sell Opportunity • Aug 05Now 25% undervalued after recent price dropOver the last 90 days, the stock has fallen 15% to NT$348. The fair value is estimated to be NT$462, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 22% over the last 3 years. Earnings per share has grown by 25%. Revenue is forecast to grow by 19% in a year. Earnings are forecast to grow by 16% in the next year.공고 • Aug 01Allied Supreme Corp. to Report Q2, 2024 Results on Aug 08, 2024Allied Supreme Corp. announced that they will report Q2, 2024 results on Aug 08, 2024분석 기사 • Jun 26Many Still Looking Away From Allied Supreme Corp. (TWSE:4770)Allied Supreme Corp.'s ( TWSE:4770 ) price-to-earnings (or "P/E") ratio of 19.9x might make it look like a buy right...Reported Earnings • May 18First quarter 2024 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2024 results: EPS: NT$6.14 (down from NT$6.81 in 1Q 2023). Revenue: NT$1.48b (down 13% from 1Q 2023). Net income: NT$489.9m (down 9.0% from 1Q 2023). Profit margin: 33% (up from 32% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue exceeded analyst estimates by 4.9%. Earnings per share (EPS) also surpassed analyst estimates by 18%. Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 6.6% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 25% per year whereas the company’s share price has increased by 22% per year.분석 기사 • May 08Allied Supreme (TWSE:4770) Is Aiming To Keep Up Its Impressive ReturnsFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...공고 • May 02Allied Supreme Corp. to Report Q1, 2024 Results on May 09, 2024Allied Supreme Corp. announced that they will report Q1, 2024 results on May 09, 2024Price Target Changed • Mar 22Price target increased by 14% to NT$419Up from NT$369, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of NT$415. Stock is up 40% over the past year. The company is forecast to post earnings per share of NT$22.89 for next year compared to NT$21.22 last year.분석 기사 • Mar 21We Think That There Are More Issues For Allied Supreme (TWSE:4770) Than Just Sluggish EarningsAllied Supreme Corp.'s ( TWSE:4770 ) stock showed strength, with investors undeterred by its weak earnings report...Upcoming Dividend • Mar 21Upcoming dividend of NT$12.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 30 April 2024. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 2.8%. Lower than top quartile of Taiwanese dividend payers (4.7%). Lower than average of industry peers (4.1%).Reported Earnings • Mar 16Full year 2023 earnings: Revenues and EPS in line with analyst expectationsFull year 2023 results: EPS: NT$21.22 (down from NT$22.54 in FY 2022). Revenue: NT$5.69b (down 7.3% from FY 2022). Net income: NT$1.68b (down 5.2% from FY 2022). Profit margin: 30% (in line with FY 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 8.4% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 33% per year whereas the company’s share price has increased by 34% per year.Price Target Changed • Mar 13Price target increased by 13% to NT$393Up from NT$348, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of NT$387. Stock is up 21% over the past year. The company is forecast to post earnings per share of NT$21.17 for next year compared to NT$22.54 last year.분석 기사 • Mar 11Allied Supreme (TWSE:4770) Is Paying Out A Dividend Of NT$12.00Allied Supreme Corp.'s ( TWSE:4770 ) investors are due to receive a payment of NT$12.00 per share on 30th of April. The...Declared Dividend • Mar 10Dividend of NT$12.00 announcedDividend of NT$12.00 is the same as last year. Ex-date: 28th March 2024 Payment date: 30th April 2024 Dividend yield will be 3.1%, which is lower than the industry average of 4.0%. Sustainability & Growth Dividend is covered by earnings (53% earnings payout ratio) but not covered by cash flows (294% cash payout ratio). The dividend has increased by an average of 41% per year over the past 3 years and payments have been stable during that time. EPS is expected to grow by 14% over the next 2 years, which should provide support to the dividend and adequate earnings cover.공고 • Mar 09+ 1 more updateAllied Supreme Corp. Announces Cash Dividend, Payable on April 30, 2024Allied Supreme Corp. announced cash dividend of TWD 959,712,000 (TWD 12 per share). Ex-rights (ex-dividend) trading date: March 28, 2024. Ex-rights (ex-dividend) record date: April 5, 2024. Payment date of common stock cash dividend distribution: April 30, 2024.Valuation Update With 7 Day Price Move • Feb 29Investor sentiment improves as stock rises 16%After last week's 16% share price gain to NT$405, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 24x in the Chemicals industry in Taiwan. Total returns to shareholders of 178% over the past three years.분석 기사 • Feb 26Allied Supreme Corp.'s (TWSE:4770) Low P/E No Reason For ExcitementWith a price-to-earnings (or "P/E") ratio of 16.7x Allied Supreme Corp. ( TWSE:4770 ) may be sending bullish signals at...Reported Earnings • Nov 17Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2023 results: EPS: NT$4.82 (down from NT$5.91 in 3Q 2022). Revenue: NT$1.23b (down 19% from 3Q 2022). Net income: NT$383.5m (down 18% from 3Q 2022). Profit margin: 31% (in line with 3Q 2022). Revenue missed analyst estimates by 9.7%. Earnings per share (EPS) exceeded analyst estimates by 5.9%. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 41% per year whereas the company’s share price has increased by 38% per year.Valuation Update With 7 Day Price Move • Nov 15Investor sentiment improves as stock rises 16%After last week's 16% share price gain to NT$365, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 21x in the Chemicals industry in Taiwan. Total returns to shareholders of 196% over the past three years.Price Target Changed • Nov 10Price target increased by 8.9% to NT$348Up from NT$319, the current price target is an average from 3 analysts. New target price is 9.5% above last closing price of NT$318. Stock is up 2.4% over the past year. The company is forecast to post earnings per share of NT$21.14 for next year compared to NT$22.54 last year.Reported Earnings • Aug 10Second quarter 2023 earnings: EPS and revenues miss analyst expectationsSecond quarter 2023 results: EPS: NT$4.75 (down from NT$5.66 in 2Q 2022). Revenue: NT$1.46b (down 8.0% from 2Q 2022). Net income: NT$375.6m (down 15% from 2Q 2022). Profit margin: 26% (down from 28% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 9.2%. Earnings per share (EPS) also missed analyst estimates by 13%. Revenue is forecast to grow 7.6% p.a. on average during the next 2 years, compared to a 5.1% growth forecast for the Chemicals industry in Taiwan.Price Target Changed • May 11Price target decreased by 16% to NT$339Down from NT$405, the current price target is an average from 2 analysts. New target price is 23% above last closing price of NT$275. Stock is up 4.8% over the past year. The company is forecast to post earnings per share of NT$23.67 for next year compared to NT$22.54 last year.Reported Earnings • May 10First quarter 2023 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2023 results: EPS: NT$6.81 (up from NT$4.58 in 1Q 2022). Revenue: NT$1.70b (up 23% from 1Q 2022). Net income: NT$538.2m (up 50% from 1Q 2022). Profit margin: 32% (up from 26% in 1Q 2022). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 4.9%. Earnings per share (EPS) also surpassed analyst estimates by 22%. Revenue is forecast to grow 9.7% p.a. on average during the next 2 years, while revenues in the Chemicals industry in Taiwan are expected to remain flat.Buying Opportunity • Apr 24Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 15%. The fair value is estimated to be NT$370, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 36% over the last 3 years. Earnings per share has grown by 51%. Revenue is forecast to grow by 24% in 2 years. Earnings is forecast to grow by 21% in the next 2 years.Buying Opportunity • Mar 28Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 10%. The fair value is estimated to be NT$368, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 36% over the last 3 years. Earnings per share has grown by 51%. Revenue is forecast to grow by 24% in 2 years. Earnings is forecast to grow by 21% in the next 2 years.Reported Earnings • Mar 24Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: NT$22.54 (up from NT$13.94 in FY 2021). Revenue: NT$6.14b (up 60% from FY 2021). Net income: NT$1.78b (up 84% from FY 2021). Profit margin: 29% (up from 25% in FY 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 4.9%. Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 2.1% growth forecast for the Chemicals industry in Taiwan.Price Target Changed • Mar 21Price target decreased by 9.0% to NT$380Down from NT$417, the current price target is an average from 2 analysts. New target price is 29% above last closing price of NT$294. Stock is up 19% over the past year. The company is forecast to post earnings per share of NT$21.48 for next year compared to NT$13.94 last year.Upcoming Dividend • Mar 17Upcoming dividend of NT$12.00 per share at 2.5% yieldEligible shareholders must have bought the stock before 24 March 2023. Payment date: 28 April 2023. Payout ratio is a comfortable 39% and the cash payout ratio is 96%. Trailing yield: 2.5%. Lower than top quartile of Taiwanese dividend payers (6.2%). Lower than average of industry peers (6.6%).Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Nov 10Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2022 results: EPS: NT$5.91 (up from NT$4.01 in 3Q 2021). Revenue: NT$1.53b (up 48% from 3Q 2021). Net income: NT$467.0m (up 68% from 3Q 2021). Profit margin: 31% (up from 27% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 6.5%. Earnings per share (EPS) exceeded analyst estimates by 7.4%. Revenue is forecast to grow 17% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Taiwan are expected to remain flat.Valuation Update With 7 Day Price Move • Oct 13Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to NT$285, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 12x in the Chemicals industry in Taiwan. Total returns to shareholders of 32% over the past year. Simply Wall St's valuation model estimates the intrinsic value at NT$567 per share.Valuation Update With 7 Day Price Move • Aug 22Investor sentiment improved over the past weekAfter last week's 21% share price gain to NT$320, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 13x in the Chemicals industry in Taiwan. Total returns to shareholders of 51% over the past year. Simply Wall St's valuation model estimates the intrinsic value at NT$595 per share.Reported Earnings • Aug 13Second quarter 2022 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2022 results: EPS: NT$5.65 (up from NT$3.04 in 2Q 2021). Revenue: NT$1.59b (up 78% from 2Q 2021). Net income: NT$444.2m (up 112% from 2Q 2021). Profit margin: 28% (up from 23% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 9.1%. Earnings per share (EPS) also surpassed analyst estimates by 15%. Over the next year, revenue is forecast to grow 29% compared to a 1.7% decline forecast for the industry in Taiwan.Reported Earnings • May 12First quarter 2022 earnings: EPS exceeds analyst expectationsFirst quarter 2022 results: EPS: NT$4.58 (up from NT$2.79 in 1Q 2021). Revenue: NT$1.38b (up 81% from 1Q 2021). Net income: NT$359.5m (up 87% from 1Q 2021). Profit margin: 26% (in line with 1Q 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 2.1%. Over the next year, revenue is forecast to grow 34% while the industry in Taiwan is not expected to grow.Reported Earnings • Mar 30Full year 2021 earnings released: EPS: NT$13.94 (vs NT$7.65 in FY 2020)Full year 2021 results: EPS: NT$13.94 (up from NT$7.65 in FY 2020). Revenue: NT$3.83b (up 46% from FY 2020). Net income: NT$966.3m (up 84% from FY 2020). Profit margin: 25% (up from 20% in FY 2020). The increase in margin was driven by higher revenue.Upcoming Dividend • Mar 24Upcoming dividend of NT$8.00 per shareEligible shareholders must have bought the stock before 31 March 2022. Payment date: 29 April 2022. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of Taiwanese dividend payers (5.4%). Lower than average of industry peers (6.3%).Valuation Update With 7 Day Price Move • Dec 31Investor sentiment improved over the past weekAfter last week's 15% share price gain to NT$291, the stock trades at a trailing P/E ratio of 22.3x. Average trailing P/E is 19x in the Chemicals industry in Taiwan. Total returns to shareholders of 118% over the past year.Reported Earnings • Nov 15Third quarter 2021 earnings released: EPS NT$4.01 (vs NT$2.40 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: NT$1.04b (up 37% from 3Q 2020). Net income: NT$277.9m (up 69% from 3Q 2020). Profit margin: 27% (up from 22% in 3Q 2020). The increase in margin was driven by higher revenue.Reported Earnings • Aug 05First quarter 2021 earnings released: EPS NT$2.79 (vs NT$0.60 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: NT$763.5m (up 83% from 1Q 2020). Net income: NT$191.8m (up 367% from 1Q 2020). Profit margin: 25% (up from 9.8% in 1Q 2020). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • May 18Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to NT$200, the stock trades at a trailing P/E ratio of 26.1x. Average trailing P/E is 15x in the Chemicals industry in Taiwan.Reported Earnings • Apr 28Full year 2020 earnings released: EPS NT$7.65 (vs NT$7.30 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: NT$2.63b (up 1.8% from FY 2019). Net income: NT$526.4m (up 5.3% from FY 2019). Profit margin: 20% (in line with FY 2019).분석 기사 • Apr 28What Allied Supreme Corp.'s (GTSM:4770) 36% Share Price Gain Is Not Telling YouAllied Supreme Corp. ( GTSM:4770 ) shares have continued their recent momentum with a 36% gain in the last month alone...Valuation Update With 7 Day Price Move • Apr 21Investor sentiment improved over the past weekAfter last week's 17% share price gain to NT$234, the stock trades at a trailing P/E ratio of 56.2x. Average trailing P/E is 21x in the Chemicals industry in Taiwan.분석 기사 • Apr 16Estimating The Intrinsic Value Of Allied Supreme Corp. (GTSM:4770)In this article we are going to estimate the intrinsic value of Allied Supreme Corp. ( GTSM:4770 ) by projecting its...공고 • Mar 12Allied Supreme Corp., Annual General Meeting, May 28, 2021Allied Supreme Corp., Annual General Meeting, May 28, 2021.Is New 90 Day High Low • Feb 24New 90-day high: NT$161The company is up 19% from its price of NT$135 on 26 November 2020. The Taiwanese market is also up 19% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it outperformed the Chemicals industry, which is up 10.0% over the same period.Is New 90 Day High Low • Jan 21New 90-day high: NT$143The company is up 21% from its price of NT$119 on 23 October 2020. The Taiwanese market is also up 21% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it outperformed the Chemicals industry, which is up 11% over the same period.분석 기사 • Dec 28Boasting A 11% Return On Equity, Is Allied Supreme Corp. (GTSM:4770) A Top Quality Stock?Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...Valuation Update With 7 Day Price Move • Nov 16Market bids up stock over the past weekAfter last week's 16% share price gain to NT$138, the stock is trading at a trailing P/E ratio of 33.1x, up from the previous P/E ratio of 28.4x. This compares to an average P/E of 18x in the Chemicals industry in Taiwan.Valuation Update With 7 Day Price Move • Nov 12Market bids up stock over the past weekAfter last week's 15% share price gain to NT$138, the stock is trading at a trailing P/E ratio of 33.1x, up from the previous P/E ratio of 28.7x. This compares to an average P/E of 21x in the Chemicals industry in Taiwan.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 4770 10년 미만 동안 배당금을 지급해 왔으며 이 기간 동안 지급액은 휘발성이었습니다.배당금 증가: 4770 의 배당금 지급이 증가했지만 회사는 5 년 동안만 배당금을 지급했습니다.배당 수익률 vs 시장Allied Supreme 배당 수익률 vs 시장4770의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (4770)2.8%시장 하위 25% (TW)1.4%시장 상위 25% (TW)5.0%업계 평균 (Chemicals)1.2%분석가 예측 (4770) (최대 3년)5.1%주목할만한 배당금: 4770 의 배당금( 2.8% )은 TW 시장에서 배당금 지급자의 하위 25%( 1.42% )보다 높습니다.고배당: 4770 의 배당금( 2.8% )은 TW 시장에서 배당금 지급자의 상위 25%( 4.96% )와 비교해 낮습니다.주주 대상 이익 배당수익 보장: 합리적인 지급 비율 ( 59.2% )을 통해 4770 의 배당금 지급은 수익으로 충당됩니다.주주 현금 배당현금 흐름 범위: 합리적으로 낮은 현금 지급 비율 ( 45.5% )로 4770 의 배당금 지급은 현금 흐름으로 잘 충당됩니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YTW 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/07/13 10:40종가2026/07/13 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Allied Supreme Corp.는 3명의 분석가가 다루고 있습니다. 이 중 2명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Yuhan ChengMasterlink Securities Investment AdvisoryJia-hong YehSinoPac Securities Investment ServiceKan-Chi LeeYuanta Research
Upcoming Dividend • Mar 25Upcoming dividend of NT$6.00 per shareEligible shareholders must have bought the stock before 01 April 2026. Payment date: 30 April 2026. Payout ratio is on the higher end at 88%, however this is supported by cash flows. Trailing yield: 5.3%. Within top quartile of Taiwanese dividend payers (5.3%). Higher than average of industry peers (2.1%).
Declared Dividend • Mar 11Dividend reduced to NT$6.00Dividend of NT$6.00 is 50% lower than last year. Ex-date: 1st April 2026 Payment date: 30th April 2026 Dividend yield will be 2.3%, which is lower than the industry average of 4.0%. Sustainability & Growth Dividend is covered by both earnings (88% earnings payout ratio) and cash flows (66% cash payout ratio). The dividend has increased by an average of 23% per year over the past 5 years and payments have been stable during that time. EPS is expected to grow by 26% over the next year, which should provide support to the dividend and adequate earnings cover.
분석 기사 • Mar 13Allied Supreme (TWSE:4770) Has Announced A Dividend Of NT$12.00Allied Supreme Corp. ( TWSE:4770 ) has announced that it will pay a dividend of NT$12.00 per share on the 30th of...
Declared Dividend • Mar 13Dividend of NT$12.00 announcedDividend of NT$12.00 is the same as last year. Ex-date: 27th March 2025 Payment date: 30th April 2025 Dividend yield will be 3.5%, which is lower than the industry average of 4.0%. Sustainability & Growth Dividend is covered by both earnings (56% earnings payout ratio) and cash flows (75% cash payout ratio). The dividend has increased by an average of 29% per year over the past 4 years and payments have been stable during that time. EPS is expected to grow by 19% over the next 2 years, which should provide support to the dividend and adequate earnings cover.
공고 • Mar 12Allied Supreme Corp. Announces Cash Dividend Distribution for the Year 2024, Payable on April 30, 2025Allied Supreme Corp. announced cash dividend distribution for the year 2024. Type and monetary amount of common stock dividend distribution: Cash dividends: TWD 959,712,000 (TWD 12 distributed per share). Ex-rights (ex-dividend) trading date: March 27, 2025; Ex-rights (ex-dividend) record date: April 4, 2025. Payment date of common stock cash dividend distribution: April 30, 2025.
Upcoming Dividend • Mar 21Upcoming dividend of NT$12.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 30 April 2024. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 2.8%. Lower than top quartile of Taiwanese dividend payers (4.7%). Lower than average of industry peers (4.1%).
Valuation Update With 7 Day Price Move • May 26Investor sentiment improves as stock rises 17%After last week's 17% share price gain to NT$266, the stock trades at a trailing P/E ratio of 26.2x. Average forward P/E is 20x in the Chemicals industry in Taiwan. Negligible returns to shareholders over past three years. Simply Wall St's valuation model estimates the intrinsic value at NT$303 per share.
Reported Earnings • May 13First quarter 2026 earnings: EPS and revenues miss analyst expectationsFirst quarter 2026 results: EPS: NT$2.00 (down from NT$2.60 in 1Q 2025). Revenue: NT$1.06b (up 9.6% from 1Q 2025). Net income: NT$201.6m (down 3.0% from 1Q 2025). Profit margin: 19% (down from 22% in 1Q 2025). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 29%. Earnings per share (EPS) also missed analyst estimates by 52%. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.
New Risk • Mar 31New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.8% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.3% average weekly change). Profit margins are more than 30% lower than last year (17% net profit margin).
Upcoming Dividend • Mar 25Upcoming dividend of NT$6.00 per shareEligible shareholders must have bought the stock before 01 April 2026. Payment date: 30 April 2026. Payout ratio is on the higher end at 88%, however this is supported by cash flows. Trailing yield: 5.3%. Within top quartile of Taiwanese dividend payers (5.3%). Higher than average of industry peers (2.1%).
New Risk • Mar 17New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 17% Last year net profit margin: 27% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Profit margins are more than 30% lower than last year (17% net profit margin).
Reported Earnings • Mar 17Full year 2025 earnings: EPS and revenues miss analyst expectationsFull year 2025 results: EPS: NT$10.20 (down from NT$21.68 in FY 2024). Revenue: NT$4.73b (down 27% from FY 2024). Net income: NT$815.9m (down 53% from FY 2024). Profit margin: 17% (down from 27% in FY 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 6.7%. Earnings per share (EPS) also missed analyst estimates by 20%. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.
Declared Dividend • Mar 11Dividend reduced to NT$6.00Dividend of NT$6.00 is 50% lower than last year. Ex-date: 1st April 2026 Payment date: 30th April 2026 Dividend yield will be 2.3%, which is lower than the industry average of 4.0%. Sustainability & Growth Dividend is covered by both earnings (88% earnings payout ratio) and cash flows (66% cash payout ratio). The dividend has increased by an average of 23% per year over the past 5 years and payments have been stable during that time. EPS is expected to grow by 26% over the next year, which should provide support to the dividend and adequate earnings cover.
Valuation Update With 7 Day Price Move • Mar 11Investor sentiment improves as stock rises 19%After last week's 19% share price gain to NT$262, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 19x in the Chemicals industry in Taiwan. Total loss to shareholders of 9.0% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at NT$248 per share.
New Risk • Mar 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
공고 • Mar 10+ 1 more updateAllied Supreme Corp., Annual General Meeting, Jun 02, 2026Allied Supreme Corp., Annual General Meeting, Jun 02, 2026. Location: no,20, hsien kung nan 2nd rd., siansi township, changhua county Taiwan
Major Estimate Revision • Jan 15Consensus revenue estimates fall by 14%The consensus outlook for revenues in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from NT$5.50b to NT$4.73b. EPS estimate fell from NT$14.78 to NT$10.91 per share. Net income forecast to grow 17% next year vs 35% growth forecast for Chemicals industry in Taiwan. Consensus price target of NT$366 unchanged from last update. Share price fell 6.1% to NT$223 over the past week.
Reported Earnings • Nov 17Third quarter 2025 earnings: EPS misses analyst expectationsThird quarter 2025 results: EPS: NT$3.05 (down from NT$5.28 in 3Q 2024). Revenue: NT$1.40b (down 21% from 3Q 2024). Net income: NT$244.0m (down 42% from 3Q 2024). Profit margin: 18% (down from 24% in 3Q 2024). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 23%. Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 6.3% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has fallen by 12% per year whereas the company’s share price has fallen by 9% per year.
Buy Or Sell Opportunity • Sep 08Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 32% to NT$320. The fair value is estimated to be NT$264, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 5.1%. Revenue is forecast to grow by 5.4% in a year. Earnings are forecast to grow by 7.5% in the next year.
Price Target Changed • Aug 17Price target increased by 15% to NT$367Up from NT$320, the current price target is an average from 4 analysts. New target price is 34% above last closing price of NT$275. Stock is down 29% over the past year. The company is forecast to post earnings per share of NT$14.78 for next year compared to NT$21.68 last year.
Reported Earnings • Aug 13Second quarter 2025 earnings: EPS and revenues miss analyst expectationsSecond quarter 2025 results: EPS: NT$2.75 (down from NT$5.01 in 2Q 2024). Revenue: NT$1.31b (down 17% from 2Q 2024). Net income: NT$220.2m (down 45% from 2Q 2024). Profit margin: 17% (down from 25% in 2Q 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 13%. Earnings per share (EPS) also missed analyst estimates by 38%. Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 3.6% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Aug 08Investor sentiment improves as stock rises 19%After last week's 19% share price gain to NT$307, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 20x in the Chemicals industry in Taiwan. Total returns to shareholders of 34% over the past three years.
Valuation Update With 7 Day Price Move • Jun 20Investor sentiment improves as stock rises 17%After last week's 17% share price gain to NT$275, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 20x in the Chemicals industry in Taiwan. Total returns to shareholders of 16% over the past three years.
공고 • May 30Allied Supreme Corp. Approves Board ElectionsAllied Supreme Corp. at its 2025 Annual General Shareholders meeting held on May 29, 2025, approved the election of Director: Hou, Chia-Sheng and Independent Director: Lu, Chien-Jung, Independent Director: Wang, Kui-Ching, Independent Director: Chien, Yu-Kuo and Independent Director: Chen, Yun-Chang.
Reported Earnings • May 13First quarter 2025 earnings: EPS and revenues miss analyst expectationsFirst quarter 2025 results: EPS: NT$2.60 (down from NT$6.14 in 1Q 2024). Revenue: NT$965.9m (down 35% from 1Q 2024). Net income: NT$207.8m (down 58% from 1Q 2024). Profit margin: 22% (down from 33% in 1Q 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 1.0%. Earnings per share (EPS) also missed analyst estimates by 5.9%. Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 4.2% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
공고 • May 01Allied Supreme Corp. to Report Q1, 2025 Results on May 08, 2025Allied Supreme Corp. announced that they will report Q1, 2025 results on May 08, 2025
Valuation Update With 7 Day Price Move • Apr 16Investor sentiment improves as stock rises 17%After last week's 17% share price gain to NT$234, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 17x in the Chemicals industry in Taiwan. Negligible returns to shareholders over past three years.
Valuation Update With 7 Day Price Move • Mar 31Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to NT$272, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 17x in the Chemicals industry in Taiwan. Total returns to shareholders of 16% over the past three years.
Major Estimate Revision • Mar 20Consensus revenue estimates fall by 14%The consensus outlook for revenues in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from NT$7.23b to NT$6.20b. EPS estimate fell from NT$24.35 to NT$18.42 per share. Net income forecast to shrink 15% next year vs 18% growth forecast for Chemicals industry in Taiwan . Consensus price target down from NT$434 to NT$384. Share price was steady at NT$343 over the past week.
Price Target Changed • Mar 19Price target decreased by 14% to NT$384Down from NT$444, the current price target is an average from 2 analysts. New target price is 11% above last closing price of NT$345. Stock is down 14% over the past year. The company is forecast to post earnings per share of NT$18.42 for next year compared to NT$21.68 last year.
Reported Earnings • Mar 15Full year 2024 earnings: EPS exceeds analyst expectationsFull year 2024 results: EPS: NT$21.68 (up from NT$21.22 in FY 2023). Revenue: NT$6.46b (up 13% from FY 2023). Net income: NT$1.73b (up 2.9% from FY 2023). Profit margin: 27% (down from 30% in FY 2023). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.7%. Revenue is forecast to grow 7.1% p.a. on average during the next 2 years, compared to a 4.9% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 11% per year.
분석 기사 • Mar 13Allied Supreme (TWSE:4770) Has Announced A Dividend Of NT$12.00Allied Supreme Corp. ( TWSE:4770 ) has announced that it will pay a dividend of NT$12.00 per share on the 30th of...
공고 • Mar 13Allied Supreme Corp., Annual General Meeting, May 29, 2025Allied Supreme Corp., Annual General Meeting, May 29, 2025, at 10:00 Taipei Standard Time. Location: no,300, ch`ing fu rd., siansi township, changhua county Taiwan
Declared Dividend • Mar 13Dividend of NT$12.00 announcedDividend of NT$12.00 is the same as last year. Ex-date: 27th March 2025 Payment date: 30th April 2025 Dividend yield will be 3.5%, which is lower than the industry average of 4.0%. Sustainability & Growth Dividend is covered by both earnings (56% earnings payout ratio) and cash flows (75% cash payout ratio). The dividend has increased by an average of 29% per year over the past 4 years and payments have been stable during that time. EPS is expected to grow by 19% over the next 2 years, which should provide support to the dividend and adequate earnings cover.
공고 • Mar 12Allied Supreme Corp. Announces Cash Dividend Distribution for the Year 2024, Payable on April 30, 2025Allied Supreme Corp. announced cash dividend distribution for the year 2024. Type and monetary amount of common stock dividend distribution: Cash dividends: TWD 959,712,000 (TWD 12 distributed per share). Ex-rights (ex-dividend) trading date: March 27, 2025; Ex-rights (ex-dividend) record date: April 4, 2025. Payment date of common stock cash dividend distribution: April 30, 2025.
Valuation Update With 7 Day Price Move • Mar 06Investor sentiment improves as stock rises 16%After last week's 16% share price gain to NT$372, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 20x in the Chemicals industry in Taiwan. Total returns to shareholders of 68% over the past three years.
공고 • Feb 28Allied Supreme Corp. to Report Q4, 2024 Results on Mar 07, 2025Allied Supreme Corp. announced that they will report Q4, 2024 results on Mar 07, 2025
New Risk • Feb 21New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Valuation Update With 7 Day Price Move • Feb 14Investor sentiment improves as stock rises 16%After last week's 16% share price gain to NT$330, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 17x in the Chemicals industry in Taiwan. Total returns to shareholders of 40% over the past three years.
분석 기사 • Feb 14There's No Escaping Allied Supreme Corp.'s (TWSE:4770) Muted EarningsAllied Supreme Corp.'s ( TWSE:4770 ) price-to-earnings (or "P/E") ratio of 14.9x might make it look like a buy right...
분석 기사 • Dec 16Why You Should Care About Allied Supreme's (TWSE:4770) Strong Returns On CapitalDid you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...
Reported Earnings • Nov 15Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behindThird quarter 2024 results: EPS: NT$5.28 (up from NT$4.82 in 3Q 2023). Revenue: NT$1.77b (up 44% from 3Q 2023). Net income: NT$422.1m (up 10% from 3Q 2023). Profit margin: 24% (down from 31% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.3%. Earnings per share (EPS) missed analyst estimates by 5.2%. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 4.8% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 9% per year.
공고 • Nov 01Allied Supreme Corp. to Report Q3, 2024 Results on Nov 08, 2024Allied Supreme Corp. announced that they will report Q3, 2024 results on Nov 08, 2024
분석 기사 • Sep 04Investors Shouldn't Overlook The Favourable Returns On Capital At Allied Supreme (TWSE:4770)What trends should we look for it we want to identify stocks that can multiply in value over the long term? In a...
Reported Earnings • Aug 12Second quarter 2024 earnings: EPS and revenues miss analyst expectationsSecond quarter 2024 results: EPS: NT$5.01 (up from NT$4.75 in 2Q 2023). Revenue: NT$1.59b (up 8.4% from 2Q 2023). Net income: NT$400.4m (up 6.6% from 2Q 2023). Profit margin: 25% (in line with 2Q 2023). Revenue missed analyst estimates by 1.6%. Earnings per share (EPS) also missed analyst estimates by 10%. Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 4.7% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 19% per year and the company’s share price has also increased by 19% per year.
분석 기사 • Aug 08A Look At The Intrinsic Value Of Allied Supreme Corp. (TWSE:4770)Key Insights Allied Supreme's estimated fair value is NT$463 based on 2 Stage Free Cash Flow to Equity Allied Supreme's...
Buy Or Sell Opportunity • Aug 05Now 25% undervalued after recent price dropOver the last 90 days, the stock has fallen 15% to NT$348. The fair value is estimated to be NT$462, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 22% over the last 3 years. Earnings per share has grown by 25%. Revenue is forecast to grow by 19% in a year. Earnings are forecast to grow by 16% in the next year.
공고 • Aug 01Allied Supreme Corp. to Report Q2, 2024 Results on Aug 08, 2024Allied Supreme Corp. announced that they will report Q2, 2024 results on Aug 08, 2024
분석 기사 • Jun 26Many Still Looking Away From Allied Supreme Corp. (TWSE:4770)Allied Supreme Corp.'s ( TWSE:4770 ) price-to-earnings (or "P/E") ratio of 19.9x might make it look like a buy right...
Reported Earnings • May 18First quarter 2024 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2024 results: EPS: NT$6.14 (down from NT$6.81 in 1Q 2023). Revenue: NT$1.48b (down 13% from 1Q 2023). Net income: NT$489.9m (down 9.0% from 1Q 2023). Profit margin: 33% (up from 32% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue exceeded analyst estimates by 4.9%. Earnings per share (EPS) also surpassed analyst estimates by 18%. Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 6.6% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 25% per year whereas the company’s share price has increased by 22% per year.
분석 기사 • May 08Allied Supreme (TWSE:4770) Is Aiming To Keep Up Its Impressive ReturnsFinding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
공고 • May 02Allied Supreme Corp. to Report Q1, 2024 Results on May 09, 2024Allied Supreme Corp. announced that they will report Q1, 2024 results on May 09, 2024
Price Target Changed • Mar 22Price target increased by 14% to NT$419Up from NT$369, the current price target is an average from 4 analysts. New target price is approximately in line with last closing price of NT$415. Stock is up 40% over the past year. The company is forecast to post earnings per share of NT$22.89 for next year compared to NT$21.22 last year.
분석 기사 • Mar 21We Think That There Are More Issues For Allied Supreme (TWSE:4770) Than Just Sluggish EarningsAllied Supreme Corp.'s ( TWSE:4770 ) stock showed strength, with investors undeterred by its weak earnings report...
Upcoming Dividend • Mar 21Upcoming dividend of NT$12.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 30 April 2024. Payout ratio is a comfortable 57% but the company is paying out more than the cash it is generating. Trailing yield: 2.8%. Lower than top quartile of Taiwanese dividend payers (4.7%). Lower than average of industry peers (4.1%).
Reported Earnings • Mar 16Full year 2023 earnings: Revenues and EPS in line with analyst expectationsFull year 2023 results: EPS: NT$21.22 (down from NT$22.54 in FY 2022). Revenue: NT$5.69b (down 7.3% from FY 2022). Net income: NT$1.68b (down 5.2% from FY 2022). Profit margin: 30% (in line with FY 2022). Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 8.4% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 33% per year whereas the company’s share price has increased by 34% per year.
Price Target Changed • Mar 13Price target increased by 13% to NT$393Up from NT$348, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of NT$387. Stock is up 21% over the past year. The company is forecast to post earnings per share of NT$21.17 for next year compared to NT$22.54 last year.
분석 기사 • Mar 11Allied Supreme (TWSE:4770) Is Paying Out A Dividend Of NT$12.00Allied Supreme Corp.'s ( TWSE:4770 ) investors are due to receive a payment of NT$12.00 per share on 30th of April. The...
Declared Dividend • Mar 10Dividend of NT$12.00 announcedDividend of NT$12.00 is the same as last year. Ex-date: 28th March 2024 Payment date: 30th April 2024 Dividend yield will be 3.1%, which is lower than the industry average of 4.0%. Sustainability & Growth Dividend is covered by earnings (53% earnings payout ratio) but not covered by cash flows (294% cash payout ratio). The dividend has increased by an average of 41% per year over the past 3 years and payments have been stable during that time. EPS is expected to grow by 14% over the next 2 years, which should provide support to the dividend and adequate earnings cover.
공고 • Mar 09+ 1 more updateAllied Supreme Corp. Announces Cash Dividend, Payable on April 30, 2024Allied Supreme Corp. announced cash dividend of TWD 959,712,000 (TWD 12 per share). Ex-rights (ex-dividend) trading date: March 28, 2024. Ex-rights (ex-dividend) record date: April 5, 2024. Payment date of common stock cash dividend distribution: April 30, 2024.
Valuation Update With 7 Day Price Move • Feb 29Investor sentiment improves as stock rises 16%After last week's 16% share price gain to NT$405, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 24x in the Chemicals industry in Taiwan. Total returns to shareholders of 178% over the past three years.
분석 기사 • Feb 26Allied Supreme Corp.'s (TWSE:4770) Low P/E No Reason For ExcitementWith a price-to-earnings (or "P/E") ratio of 16.7x Allied Supreme Corp. ( TWSE:4770 ) may be sending bullish signals at...
Reported Earnings • Nov 17Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2023 results: EPS: NT$4.82 (down from NT$5.91 in 3Q 2022). Revenue: NT$1.23b (down 19% from 3Q 2022). Net income: NT$383.5m (down 18% from 3Q 2022). Profit margin: 31% (in line with 3Q 2022). Revenue missed analyst estimates by 9.7%. Earnings per share (EPS) exceeded analyst estimates by 5.9%. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Chemicals industry in Taiwan. Over the last 3 years on average, earnings per share has increased by 41% per year whereas the company’s share price has increased by 38% per year.
Valuation Update With 7 Day Price Move • Nov 15Investor sentiment improves as stock rises 16%After last week's 16% share price gain to NT$365, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 21x in the Chemicals industry in Taiwan. Total returns to shareholders of 196% over the past three years.
Price Target Changed • Nov 10Price target increased by 8.9% to NT$348Up from NT$319, the current price target is an average from 3 analysts. New target price is 9.5% above last closing price of NT$318. Stock is up 2.4% over the past year. The company is forecast to post earnings per share of NT$21.14 for next year compared to NT$22.54 last year.
Reported Earnings • Aug 10Second quarter 2023 earnings: EPS and revenues miss analyst expectationsSecond quarter 2023 results: EPS: NT$4.75 (down from NT$5.66 in 2Q 2022). Revenue: NT$1.46b (down 8.0% from 2Q 2022). Net income: NT$375.6m (down 15% from 2Q 2022). Profit margin: 26% (down from 28% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 9.2%. Earnings per share (EPS) also missed analyst estimates by 13%. Revenue is forecast to grow 7.6% p.a. on average during the next 2 years, compared to a 5.1% growth forecast for the Chemicals industry in Taiwan.
Price Target Changed • May 11Price target decreased by 16% to NT$339Down from NT$405, the current price target is an average from 2 analysts. New target price is 23% above last closing price of NT$275. Stock is up 4.8% over the past year. The company is forecast to post earnings per share of NT$23.67 for next year compared to NT$22.54 last year.
Reported Earnings • May 10First quarter 2023 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2023 results: EPS: NT$6.81 (up from NT$4.58 in 1Q 2022). Revenue: NT$1.70b (up 23% from 1Q 2022). Net income: NT$538.2m (up 50% from 1Q 2022). Profit margin: 32% (up from 26% in 1Q 2022). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 4.9%. Earnings per share (EPS) also surpassed analyst estimates by 22%. Revenue is forecast to grow 9.7% p.a. on average during the next 2 years, while revenues in the Chemicals industry in Taiwan are expected to remain flat.
Buying Opportunity • Apr 24Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 15%. The fair value is estimated to be NT$370, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 36% over the last 3 years. Earnings per share has grown by 51%. Revenue is forecast to grow by 24% in 2 years. Earnings is forecast to grow by 21% in the next 2 years.
Buying Opportunity • Mar 28Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 10%. The fair value is estimated to be NT$368, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 36% over the last 3 years. Earnings per share has grown by 51%. Revenue is forecast to grow by 24% in 2 years. Earnings is forecast to grow by 21% in the next 2 years.
Reported Earnings • Mar 24Full year 2022 earnings: EPS exceeds analyst expectationsFull year 2022 results: EPS: NT$22.54 (up from NT$13.94 in FY 2021). Revenue: NT$6.14b (up 60% from FY 2021). Net income: NT$1.78b (up 84% from FY 2021). Profit margin: 29% (up from 25% in FY 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 4.9%. Revenue is forecast to grow 10% p.a. on average during the next 2 years, compared to a 2.1% growth forecast for the Chemicals industry in Taiwan.
Price Target Changed • Mar 21Price target decreased by 9.0% to NT$380Down from NT$417, the current price target is an average from 2 analysts. New target price is 29% above last closing price of NT$294. Stock is up 19% over the past year. The company is forecast to post earnings per share of NT$21.48 for next year compared to NT$13.94 last year.
Upcoming Dividend • Mar 17Upcoming dividend of NT$12.00 per share at 2.5% yieldEligible shareholders must have bought the stock before 24 March 2023. Payment date: 28 April 2023. Payout ratio is a comfortable 39% and the cash payout ratio is 96%. Trailing yield: 2.5%. Lower than top quartile of Taiwanese dividend payers (6.2%). Lower than average of industry peers (6.6%).
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 9 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Nov 10Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behindThird quarter 2022 results: EPS: NT$5.91 (up from NT$4.01 in 3Q 2021). Revenue: NT$1.53b (up 48% from 3Q 2021). Net income: NT$467.0m (up 68% from 3Q 2021). Profit margin: 31% (up from 27% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 6.5%. Earnings per share (EPS) exceeded analyst estimates by 7.4%. Revenue is forecast to grow 17% p.a. on average during the next 3 years, while revenues in the Chemicals industry in Taiwan are expected to remain flat.
Valuation Update With 7 Day Price Move • Oct 13Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to NT$285, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 12x in the Chemicals industry in Taiwan. Total returns to shareholders of 32% over the past year. Simply Wall St's valuation model estimates the intrinsic value at NT$567 per share.
Valuation Update With 7 Day Price Move • Aug 22Investor sentiment improved over the past weekAfter last week's 21% share price gain to NT$320, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 13x in the Chemicals industry in Taiwan. Total returns to shareholders of 51% over the past year. Simply Wall St's valuation model estimates the intrinsic value at NT$595 per share.
Reported Earnings • Aug 13Second quarter 2022 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2022 results: EPS: NT$5.65 (up from NT$3.04 in 2Q 2021). Revenue: NT$1.59b (up 78% from 2Q 2021). Net income: NT$444.2m (up 112% from 2Q 2021). Profit margin: 28% (up from 23% in 2Q 2021). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 9.1%. Earnings per share (EPS) also surpassed analyst estimates by 15%. Over the next year, revenue is forecast to grow 29% compared to a 1.7% decline forecast for the industry in Taiwan.
Reported Earnings • May 12First quarter 2022 earnings: EPS exceeds analyst expectationsFirst quarter 2022 results: EPS: NT$4.58 (up from NT$2.79 in 1Q 2021). Revenue: NT$1.38b (up 81% from 1Q 2021). Net income: NT$359.5m (up 87% from 1Q 2021). Profit margin: 26% (in line with 1Q 2021). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 2.1%. Over the next year, revenue is forecast to grow 34% while the industry in Taiwan is not expected to grow.
Reported Earnings • Mar 30Full year 2021 earnings released: EPS: NT$13.94 (vs NT$7.65 in FY 2020)Full year 2021 results: EPS: NT$13.94 (up from NT$7.65 in FY 2020). Revenue: NT$3.83b (up 46% from FY 2020). Net income: NT$966.3m (up 84% from FY 2020). Profit margin: 25% (up from 20% in FY 2020). The increase in margin was driven by higher revenue.
Upcoming Dividend • Mar 24Upcoming dividend of NT$8.00 per shareEligible shareholders must have bought the stock before 31 March 2022. Payment date: 29 April 2022. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of Taiwanese dividend payers (5.4%). Lower than average of industry peers (6.3%).
Valuation Update With 7 Day Price Move • Dec 31Investor sentiment improved over the past weekAfter last week's 15% share price gain to NT$291, the stock trades at a trailing P/E ratio of 22.3x. Average trailing P/E is 19x in the Chemicals industry in Taiwan. Total returns to shareholders of 118% over the past year.
Reported Earnings • Nov 15Third quarter 2021 earnings released: EPS NT$4.01 (vs NT$2.40 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: NT$1.04b (up 37% from 3Q 2020). Net income: NT$277.9m (up 69% from 3Q 2020). Profit margin: 27% (up from 22% in 3Q 2020). The increase in margin was driven by higher revenue.
Reported Earnings • Aug 05First quarter 2021 earnings released: EPS NT$2.79 (vs NT$0.60 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: NT$763.5m (up 83% from 1Q 2020). Net income: NT$191.8m (up 367% from 1Q 2020). Profit margin: 25% (up from 9.8% in 1Q 2020). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • May 18Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to NT$200, the stock trades at a trailing P/E ratio of 26.1x. Average trailing P/E is 15x in the Chemicals industry in Taiwan.
Reported Earnings • Apr 28Full year 2020 earnings released: EPS NT$7.65 (vs NT$7.30 in FY 2019)The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: NT$2.63b (up 1.8% from FY 2019). Net income: NT$526.4m (up 5.3% from FY 2019). Profit margin: 20% (in line with FY 2019).
분석 기사 • Apr 28What Allied Supreme Corp.'s (GTSM:4770) 36% Share Price Gain Is Not Telling YouAllied Supreme Corp. ( GTSM:4770 ) shares have continued their recent momentum with a 36% gain in the last month alone...
Valuation Update With 7 Day Price Move • Apr 21Investor sentiment improved over the past weekAfter last week's 17% share price gain to NT$234, the stock trades at a trailing P/E ratio of 56.2x. Average trailing P/E is 21x in the Chemicals industry in Taiwan.
분석 기사 • Apr 16Estimating The Intrinsic Value Of Allied Supreme Corp. (GTSM:4770)In this article we are going to estimate the intrinsic value of Allied Supreme Corp. ( GTSM:4770 ) by projecting its...
공고 • Mar 12Allied Supreme Corp., Annual General Meeting, May 28, 2021Allied Supreme Corp., Annual General Meeting, May 28, 2021.
Is New 90 Day High Low • Feb 24New 90-day high: NT$161The company is up 19% from its price of NT$135 on 26 November 2020. The Taiwanese market is also up 19% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it outperformed the Chemicals industry, which is up 10.0% over the same period.
Is New 90 Day High Low • Jan 21New 90-day high: NT$143The company is up 21% from its price of NT$119 on 23 October 2020. The Taiwanese market is also up 21% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it outperformed the Chemicals industry, which is up 11% over the same period.
분석 기사 • Dec 28Boasting A 11% Return On Equity, Is Allied Supreme Corp. (GTSM:4770) A Top Quality Stock?Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
Valuation Update With 7 Day Price Move • Nov 16Market bids up stock over the past weekAfter last week's 16% share price gain to NT$138, the stock is trading at a trailing P/E ratio of 33.1x, up from the previous P/E ratio of 28.4x. This compares to an average P/E of 18x in the Chemicals industry in Taiwan.
Valuation Update With 7 Day Price Move • Nov 12Market bids up stock over the past weekAfter last week's 15% share price gain to NT$138, the stock is trading at a trailing P/E ratio of 33.1x, up from the previous P/E ratio of 28.7x. This compares to an average P/E of 21x in the Chemicals industry in Taiwan.